| DHX33 |
Q9H6R0
|
DEAH-box helicase 33
|
Enzyme
|
9.1E-06 |
0.751 |
0.192 |
| HOXC5 |
Q00444
|
homeobox C5
|
Transcription factor
|
5.8E-05 |
0.682 |
0.269 |
| MEF2B |
Q02080
|
myocyte enhancer factor 2B
|
|
9.3E-04 |
0.670 |
0.308 |
| LTK |
P29376
|
leukocyte receptor tyrosine kinase
|
Kinase
|
9.3E-26 |
0.743 |
0.308 |
| LIMD1 |
Q9UGP4
|
LIM domains containing 1
|
Transcription factor
|
0.42 |
0.691 |
0.346 |
| DYRK2 |
Q92630
|
dual specificity tyrosine phosphorylation regulated kinase 2
|
Kinase
|
1.00 |
0.670 |
0.346 |
| SMC4 |
Q9NTJ3
|
structural maintenance of chromosomes 4
|
|
1.7E-05 |
0.678 |
0.346 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| GPR34 |
Q9UPC5
|
G protein-coupled receptor 34
|
G-protein coupled receptor
|
0.26 |
0.743 |
0.346 |
| GPANK1 |
O95872
|
G-patch domain and ankyrin repeats 1
|
|
3.2E-07 |
0.769 |
0.385 |
| PLEKHG2 |
Q9H7P9
|
pleckstrin homology and RhoGEF domain containing G2
|
|
1.4E-09 |
0.705 |
0.423 |
| C6orf47 |
O95873
|
chromosome 6 open reading frame 47
|
|
6.6E-02 |
0.722 |
0.423 |
| TMEM260 |
Q9NX78
|
transmembrane protein 260
|
|
4.7E-19 |
0.769 |
0.423 |
| KRT81 |
Q14533
|
keratin 81
|
|
1.2E-18 |
0.659 |
0.462 |
| CD37 |
P11049
|
CD37 molecule
|
|
4.4E-06 |
0.647 |
0.462 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| MOS |
P00540
|
MOS proto-oncogene, serine/threonine kinase
|
Kinase
|
0.59 |
0.617 |
0.500 |
| TNFAIP8 |
O95379
|
TNF alpha induced protein 8
|
|
0.38 |
0.601 |
0.500 |
| CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
| RORB |
Q92753
|
RAR related orphan receptor B
|
Nuclear receptor
|
1.00 |
0.644 |
0.500 |
| CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
| KMT5A |
Q9NQR1
|
lysine methyltransferase 5A
|
|
0.99 |
0.633 |
0.538 |
| HSPH1 |
Q92598
|
heat shock protein family H (Hsp110) member 1
|
|
1.00 |
0.650 |
0.538 |
| MIR502 |
|
microRNA 502
|
|
|
0.641 |
0.538 |